Publications by authors named "Shaza Alyazjeen"
Front Oncol
February 2024
Article Synopsis
- Advances in molecular diagnostics have led to better treatment options for pediatric CNS tumors, but testing access is limited in low- and middle-income countries (LMICs), necessitating further analysis of their effectiveness.
- A review of next-generation sequencing (NGS) testing at KHCC in Jordan revealed that 14% of discussed patients were included, with a median age of 9.5 years and various tumor types primarily being low-grade and high-grade gliomas.
- NGS testing identified targetable genetic alterations in 59% of cases, influencing treatment decisions, with processing averages around 23.5 days and costing approximately $1,000 per sample.
